Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression.
Buocikova V, Tyciakova S, Pilalis E, Mastrokalou C, Urbanova M, Matuskova M, Demkova L, Medova V, Longhin EM, Rundén-Pran E, Dusinska M, Rios-Mondragon I, Cimpan MR, Gabelova A, Soltysova A, Smolkova B, Chatziioannou A.
Buocikova V, et al. Among authors: gabelova a.
Front Pharmacol. 2022 Oct 5;13:991751. doi: 10.3389/fphar.2022.991751. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36278182
Free PMC article.